Pharmacovigilance in the COVID-19 Era and Beyond
Categorías:
Right now, millions of patients are being dosed with vaccines for COVID-19, which have had accelerated development timelines in order to provide emergency use. This is a first in our industry, and it presents safety monitoring challenges for pharmaceutical companies managing an unprecedented volume of data to ensure that the benefits to patients outweigh the risks. How can they keep up – now, and in the future?Carol Aliyar, Executive Vice President, Global Head of Safety and Pharmacovigilance...
